{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-24-001491","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.671567+00:00","generated_at":"2026-05-30T02:06:35.350296+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Director Maeve O'Meara resigns effective Jan 1, 2025; Gabriel Ling to become independent director","bullets":["Maeve O'Meara notified board of her resignation as director for personal reasons, effective January 1, 2025.","Resignation is not the result of any disagreement with the company, board, or operations.","Board determined that existing director Gabriel Ling will qualify as independent as of the Effective Date.","After the departure, a majority of independent directors will remain on the board."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-24-001491","json":"https://secwatch.observer/filing/0001079973-24-001491.json","markdown":"https://secwatch.observer/filing/0001079973-24-001491.md","text":"https://secwatch.observer/filing/0001079973-24-001491.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000107997324001491/0001079973-24-001491-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000107997324001491/toi_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:06:35.350296+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fe51605f79","claim":"Maeve O'Meara resigned as Director at Oncology Institute, Inc..","evidence_excerpt":"On November 8, 2024, Maeve O’Meara notified the Board of Directors of The Oncology Institute, Inc. (the “Company”) of her intention to resign as a director of the Company for personal reasons, effective as of January 1, 2025 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997324001491/0001079973-24-001491-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}